close
close

Top Asian dividend shares that can be seen in March 2025

While the global markets are uncertain trade policy and economic growth, the Asian markets are attracting attention with their potential for stability and income generation through dividend shares. In this environment, the selection of dividend shares that offer consistent payouts and resistance in the middle of market fluctuations can be a strategic approach for investors who strive for reliable returns.

name

Dividend yield

Dividend assessment

Wuliangye Yibinltd (Szse: 000858)

3.66%

★★★★earch

CAC Holdings (Tse: 4725)

5.02%

★★★★earch

Daito Trust Constructionltd (TSE: 1878)

4.12%

★★★★earch

Intelligent wave (tse: 4847)

3.85%

★★★★earch

China South Publishing & Media Group (Shse: 601098)

4.32%

★★★★earch

Gakkyushaltd (tse: 9769)

3.97%

★★★★earch

Doshishaltd (tse: 7483)

3.83%

★★★★earch

Guangxi Liuyao group (SHSE: 603368)

3.22%

★★★★earch

Huayu Automotive Systems (Shse: 600741)

4.28%

★★★★earch

EJ Holdings (Tse: 2153)

4.87%

★★★★earch

Click here to display the full list of 1131 shares from our Top Asian Dividends Stocks Screener.

We will watch some of the best selection from our screen tool.

Simply wall st dividend rating: ★★★★ ☆itch

Overview: The JW Lifescience Corporation specializes in the provision of national infusion solutions in both South Korea and internationally, with market capitalization of 175.44 billion ₩ capitalization of 55.44 billion.

Operations: The JW Lifescience Corporation primarily achieves income from its pharmaceutical segment, which corresponds to $ 221.32 million.

Dividend yield: 4.4%

JW Lifescience's dividend yield of 4.41% places it at the top 25% of the Korean market payers, although seven -year history shows unreliable payments without growth. Nevertheless, dividends are well covered by profits and cash flows, with the payout rates of 26.9% or 16.3%. In addition to the generation of income generation, the trade under the estimated current value indicates, but investors should be careful with the short dividend history and the volatility of the payments of the share.

Kose: A234080 Dividend history as in March 2025

Simply wall st dividend rating: ★★★★ ☆itch

Overview: Consun Pharmaceutical Group Limited Researches, develops, produces and sells Chinese medication and medical contrast medium in China with a market capitalization of $ 7.08 billion.

Operations: The income of the Consun Pharmaceutical Group mainly comes from the Consun Pharmaceutical segment and contribute CN -2.33 billion yen and the Yulin Pharmaceutical Segment, which add CN -409.99 million CN.